Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Washington for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Washington only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Washington (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Kenneth Fung (NPI 1629291406)

Field	Value
Entity Type	Individual
Organization	Kenneth Fung
Address	4300 Talbot Rd S Ste 300
City	Renton
State	WA
ZIP	98055
Taxonomy	Ophthalmology Physician
NPI Enumerated	April 10, 2007

Payer Source	Total Paid
Medicare	$1.6M
Medicaid	$0

Key Findings

This provider’s Medicare activity is heavily concentrated in intravitreal anti-VEGF therapy: J0178 (Injection, aflibercept) alone accounts for $978.1K and 62.8% of the provider’s Medicare revenue, and the top three Medicare codes together account for 82.4% of total Medicare revenue. Those top three codes (J0178, J2777, 67028) point to a practice model centered on frequent intravitreal injections and related vitreous procedures rather than broad primary ophthalmology office visits.

Operationally, the mix of high-revenue procedural and drug codes (J0178, J2777, 67028) combined with elevated imaging and photography codes (92014, 92134, 92250) suggests this clinician runs a retina-focused practice that pairs injection therapy with substantial diagnostic imaging. High-volume imaging codes support on-site retinal diagnostics and monitoring capacity to manage chronic retinal conditions that require ongoing injections and follow-up.

The provider’s Medicare vs. Medicaid payer mix is effectively single-payer: lifetime Medicare revenue is $1.6M while there is no Medicaid billing on file. This means the provider’s public-payer exposure is concentrated entirely in Medicare and any Medicaid patient care is either absent or billed under another group/NPI not shown here.

Competitive standing on the headline drug code is within the middle of national peers: J0178 ranks #873 of 3204 providers (73th percentile) which the source labels as “typical, unremarkable volume,” indicating this clinician is neither a national outlier nor a low-volume user despite J0178 driving the majority of revenue. By contrast, some diagnostic and imaging codes are notable outliers: 92014 and 92134 both sit at the 94th percentile and 92250 at the 97th percentile versus national peers, indicating markedly higher-than-typical imaging and photography volume for an ophthalmology practice.

There are contrasts across specific biologic drug codes that refine competitive nuance: J2777 (faricimab) generates $186.2K and ranks in the 34th percentile (typical), while J2778 (ranibizumab) shows modest utilization with 150 claims and ranks in the 4th percentile nationally. This pattern suggests therapeutic preference or stocking patterns that favor aflibercept and faricimab over ranibizumab in this provider’s billing profile.

Procedure-level activity shows focused surgical/interventional practice but limited high-level office E/M volume: 67028 (intravitreal injection procedure) contributes $119.4K and ranks in the 72th percentile (typical), whereas common E/M codes like 99214, 99213, and 99215 appear at low absolute volumes and lower percentiles. That indicates revenue and clinical throughput are dominated by procedure and drug reimbursement rather than by high-volume, high-level evaluation-and-management visits.

The provider demonstrates sustained market presence, with an NPI enumerated on 2007-04-10 (~19 years ago), which supports interpretation of these patterns as stable practice behavior rather than a short-term anomaly. Long tenure combined with concentrated revenue streams is consistent with an established retina-focused practice model.

There are several secondary revenue contributors that are above typical peer volume for ophthalmic imaging: 92134 ($44K, 94th percentile) and 92250 ($20.3K, 97th percentile). These elevated imaging code percentiles reinforce that ongoing diagnostic surveillance and retinal imaging are a core service line that complements the high proportion of injection-based reimbursement.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

19 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,430	$680	$978.1K
J2777	Injection, faricimab‑svoa, 0.1 mg	6,420	$30	$186.2K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,140	$110	$119.4K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	850	$100	$83.7K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,330	$30	$44K
J2778	Injection, ranibizumab, 0.1 mg	150	$190	$27.9K
J7999	Compounded drug, not otherwise classified	310	$70	$22.6K
92250	Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,…	640	$30	$20.3K
67210	The provider destroys a lesion of the retina using a laser beam that heats up the tissue.	30	$460	$13.7K
92242	The provider injects two different special dyes into one or both eyes that cause the blood vessels to stand out in photographic images timed so that multiple frames are taken in rapid succession. He…	50	$240	$12.4K

Showing 1–10 of 19

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Washington Distribution

Kenneth Fung — 2 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Washington

Full comparison — all codes billed, vs. state median

19 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2777	37	50	12,780	$30	$599.7K
J0178	25	90	470	$680	$597.2K
J2778	25	30	510	$180	$117.1K
67028	37	110	550	$90	$72.9K
67036	15	20	20	$1,140	$28.6K
92242	12	20	50	$210	$19.7K
92014	25	790	110	$80	$16.8K
J7999	14	70	150	$70	$15.9K
99214	8,629	10,860	100	$80	$13.6K
J9035	16	40	70	$50	$10.9K

Showing 1–10 of 19

Related Providers

Other providers that share a Tax Identification Number (TIN) with Kenneth Fung, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Sound Retina Ps	WA	Specialist	$0	$7.4M
Retina Institute, PLLC	WA	Retina Specialist (Ophthalmology) Physician	$0	$5.5M
Himanshu Banda	WA	Retina Specialist (Ophthalmology) Physician	$5.1M	$0
Mark Nelson	WA	Ophthalmology Physician	$4.3M	$0
Anthony Truxal	WA	Ophthalmology Physician	$3.7M	$0
Matthew Asano	CO	Ophthalmology Physician	$2M	$0
Benjamin Reiss	WA	Retina Specialist (Ophthalmology) Physician	$1.9M	$0
George Ko	WA	Retina Specialist (Ophthalmology) Physician	$1.7M	$0
Barton Blackorby	MO	Retina Specialist (Ophthalmology) Physician	$1.1M	$0
Jay Haynie	WA	Optometrist	$394.5K	$0

Nearby Providers

Other providers in the same ZIP code as Kenneth Fung, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Public Hospital District 1 Of King County	WA	General Acute Care Hospital	$0	$120.6M
Valley Medical Group-renton	WA	General Acute Care Hospital	$0	$28.3M
Associated Emergency Room Physicians, Inc P.s.	WA	Emergency Medicine Physician	$0	$12M
Valley Children's Clinic	WA	Pediatric Adolescent Medicine Physician	$0	$5.2M
Proliance Surgery Center At Valley, LLC	WA	Ambulatory Surgical Clinic/Center	$3.3M	$0
Vantage Radiology & Diagnostic Services, A Professional Services Corp	WA	Diagnostic Radiology Physician	$0	$2.6M
Renton Regional Fire Authority	WA	Land Ambulance	$229.9K	$186.7K
Craig Fujisaki	WA	Dermatology Physician	$376.9K	$0
Timothy Alton	WA	Orthopaedic Surgery Physician	$313.4K	$0
William Barrett	WA	Orthopaedic Surgery Physician	$272.7K	$0

Kenneth Fung — Billing Profile & Reimbursement Data

Sign up for Kenneth Fung — Billing Profile & Reimbursement Data policy alerts

Kenneth Fung — Billing Profile & Reimbursement Data

Sign up for Kenneth Fung — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References